Margarita Suardiaz
Malaga, AN 29009, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis.
Journal: Neurobiology of disease
Published: May 09, 2018
Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 11, 2016
Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis.
Journal: British journal of pharmacology
Published: July 29, 2016
Spinal cord compression injury in lysophosphatidic acid 1 receptor-null mice promotes maladaptive pronociceptive descending control.
Journal: European journal of pain (London, England)
Published: February 06, 2015
TRAIL and TRAIL receptors splice variants during long-term interferon β treatment of patients with multiple sclerosis: evaluation as biomarkers for therapeutic response.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: November 17, 2014
Computational and biological evaluation of N-octadecyl-N'-propylsulfamide, a selective PPARα agonist structurally related to N-acylethanolamines.
Journal: PloS one
Published: October 28, 2013
Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis
Journal: Revista de neurologia
Published: January 12, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026